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Abstract This study evaluated the fiscal impact attributed to recent policy changes that limited funding to public ferti l i ty clinics in
Denmark. Taking Into consideration that introducing patient co-payments wil l influence the numbers of couples treated, the number
of children born every year from assisted reproductive technology will be affected. To reflect the government perspective, the
model assessed the average life course of a cohort of assisted-conception singletons taking into consideration age-specific,
per-capita government transfers (e.g. education, health care, family allowances, education, pensions) and lifetime gross tax con-
tributions to derive the discounted net tax contribution from assisted-conception singletons. An investment of €11,078 in a mother
aged <40 to achieve an assisted-conception singleton was valued at €154,100 in cumulative discounted net tax revenue when the
child reaches age 50. A reduction in the number of live births generated additional savings of €67-112 million due to reduced gov-
ernment transfers by age 25. However, by age 50, because of fewer children born and consequently fewer tax payers, a €74-123
million loss to government was estimated. The projected discounted net tax revenue attributed to assisted-conception children sug-
gests that publicly funded treatment provides economic benefits to government over the lifetime of the conceived children. P^
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Introduction
The age of austerity is underway across Europe as govern-
ments seek to minimize spending on public programmes
to rein in government debt accumulated during the cur-
rent/recent economic crisis and prepare for the looming fis-
cal effects of ageing populations (Onaran, 2010). This 1s
particularly relevant within health services seeking to find
ways to prioritize care and identifying the most cost-
effective services to maximize health gains with limited
resources (Elshaug et al., 2009). However, a recent publica-
tion describing the relationship between public spending on
social and health services warns of the potential implica-
tions of cost cutting on all-cause mortality (Stuckler
et al., 2010).
Public funding challenges for assisted reproductive
technology are not new, with only six of 57
countries recently surveyed providing fully funded treat-
ments (Jones et al., 2007). Explanations for limited funds
for assisted reproduction Include the perception of
Infertility as a low health priority and the questioning of
infertility as an illness within the wider healthcare frame-
work (Hoorens et al., 2008; McWhirter and McQueen,
2000).
In June 2010 the Danish government signalled its desire
to cut funding for both assisted as well as non-assisted
reproduction treatments, such as Intrauterine insemina-
tions with husband or donor semen, with the aim of pass-
Ing a greater share of costs onto the couples seeking care
(Lovforslag, 2010). Despite overwhelming evidence that
increasing patient co-payments leads to dramatic reduc-
tions in the number of treatment cycles (Griesinger
et al., 2007), national insurers continually seek to push
costs to consumers for a technology often considered
controversial. In Germany, cutting funds to fertility treat-
ments 1n 2004 resulted in an estimated 10,000 fewer
births in 1 year (Thaele and Uszkoreit, 2007). In the
Danish context, the price increase represents an
approximate 500% increase 1n costs paid by Infertile cou-
ples, from approximately €318 to €1840 per cycle of IVF
and intracytoplasmic sperm injection (ICSI) (Lovforslag,
2010).
The aim of this study is to assess the short- and
long-term fiscal consequences of Introducing patient
co-payments for assisted reproductive technology in
Danish public fertility cUnics. To accomplish this, this
study derives the discounted net tax revenue attributed
to changes in government fiscal transfers that arise from
ass1sted-concept1on children. In contrast with previous
studies employing this methodological framework that
considered an IVF singleton (Connolly et al., 2009a), the
current study directly assesses a policy change intro-
duced 1n January 2011 and applies the method to the
annual birth cohort of assisted-conception children in
Denmark. The underlying premise, supported by the
price-elasticity literature (Connolly et al., 2009b;
Ringel et al., 2005), is that Increasing patient costs will
serve as a barrier for many couples, therefore fewer




The study described here Involved no human subjects or col-
lection of medical data, consequently no ethical approval
was required for conducting the analysis.
Modelling framework
The model estimates whether publicly funded fertility
treatments represents a good use of government resources
by evaluating the lifetime net tax revenue of an
assisted-conception child for a cohort of assisted-
conception children born in Danish public clinics in 2009.
To accomplish this, the model simulates the average life
course of Danish citizens from the government perspective,
taking Into consideration direct fiscal transfers paid by gov-
ernment and age-specific tax receipts paid to government
(Connolly et al., 2009a). The framework is based on the
methodology of generational accounting used by govern-
ments to evaluate lifetime tax burdens across generations
based on social-benefit promises and who will be required
to pay for them (Kotlikoff, 1992). The generational account-
ing methodology is used to estimate the long-term fiscal
impact of policy changes on government accounts, in which
demography is the underlying element that Influences gov-
ernment costs; therefore, it is suitable for estimating the
Impact of funding fertility programmes accountable for
-9.0% of national births (Danish Fertility Registry, 2010).
The model is constructed using age-strat1fied per-capita
transfers for a range of social benefits in Denmark. Further-
more, age-spedfic transfers to government in the form of
tax revenues are accounted for in the model. Applying this
framework, an annualized balance sheet was constructed
at the individual level to establish the lifetime net tax con-
tributions. All costs In the model have been converted from
Danish Krones (DKK) to Euros (€) based on an exchange rate
of €1 = 7.45 DKK. Broadly speaking there are four major life
stages considered in the model: early child, education,
working and retirement (Svensson et al., 2008).
Costs per live birth
To assess the economic Impact of public investments In
assisted reproductive technology, it was necessary to calcu-
late the cost per live birth using IVF/ICSI. Based on current
practices which includes ovarian stimulation, pituitary
desensitization, oocyte retrieval, embryo transfer, and phy-
sician costs, this study estimated an average cost per cycle
of approximately €2675 which is broadly aligned with costs
1n other European countries (Connolly et al., 2010). The
costs per cycle were then applied to treatment success
rates for women aged <40 and 240 obtained from the Dan-
ish Fertility Society assisted reproduction registry (Danish
Fertility Registry, 2010). More than 90% of treatments are
in women aged <40, due to an age limit of 40 years in public
fertility clinics. Based on success rates for 2009, this study
derived a direct cost per live birth of €11,078 and €26,100
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Table 1 Transfer payments from Danish government to citizens.
DescriptionBenefit
Family allowance (Gunnersen and Bisgaard,
2010)
Maternity benefit (Gunnersen and Bisgaard,
2010)
Annual education costs p)er student (Danish
Ministry of Education, 2010)
Public pension per annum (OECD, 2009)
Cash transfers
Sickness benefit (Gunnersen and Bisgaard,
2010)
Unemployment benefit (AUH01 )
(Gunnersen and Bisgaard, 2010)
Cash benefits (K0NT3) (Schulz, 2010)
Rent subsidy (Ministry of Social Affairs,
2008)
Housing allowance elderly (Ministry of
Social Affairs, 2008)
Child 0 2 years: €2206
Child 3-6 years: €1746
Child 7-17 years: €1373
€23,533 per birth estimated from aggregated expenditure and beneficiary data in
2008
Grades 1-6: €6987; grades 7-10: €7076; youth education: €8260; higher
education: €12,224 per annum
Basic scheme (public old age pension, folkepension): €7789
Targeted components (average of single and married component): €7841
Supplementary pension benefit for economically disadvantaged elderly: €846
The weekly sickness benefit of €487 was adjusted for proportion of workers
between 18 and 67 at every age receiving sickness benefits.
Age-specific government expenditure on unemployment benefits was divided by
age-specific proportion of people unemployed between the ages of 18-67. The
average per-capita transfer across all ages between 18 and 67 was €536
The age-specific, per-capita transfer was estimated at each year for those aged
18-67: €667 per annum
Average rent subsidy to working adults derived from aggregate figures.
Annualized f)er-capita transfer of €121 applied in every year
Average allowance derived from aggregate data. Annual per-capita transfer of
€1446 applied every year from age >67
for women aged <40 and >40, respectively. This value takes
into consideration cycles that do not lead to live births and
is comparable with previous Danish estimates (Ingerslev
et al., 2005). In the absence of long-term data suggesting
IVF/ICSI-conceived children face impaired abilities and
downstream economic consequences, these children have
been assumed to be similar to naturally conceived children
(Leunens et al., 2008).
Healthcare spending
Healthcare expenditure was obtained from Statistics Den-
mark. Age-specific data were derived from aggregate cost
data by age and divided by population cohorts. The
per-capita pharmaceutical expenditure reported by Statis-
tics Denmark and adjusted for grov/th was applied every
year (Gunnersen and Bisgaard, 2010). Long-term nursing
costs for institutionalized and home care were included
based on aggregated expenditure data from the Ministry of
Social Affairs and divided by the age-cohort utilizing ser-
vices to derive a per-capita cost applied from age 60
onwards (Schulz, 2010). Considering the importance of
healthcare spending on government accounts, several infla-
tionary parameters were explored in the sensitivity analysis.
Family support
The age-specific child benefits provided to families was also
included in the analysis (Gunnersen and Bisgaard, 2010).
Furthermore, the ordinary child allowance (€630 per
annum) and extra child allowance (€642 per annum) based
on the proportion of children raised in single-parent homes
were included (Gunnersen and Bisgaard, 2010; RDMFA,
2009). A fixed cost of €23,500 associated with
maternity-leave and parental-leave benefits was accounted
for the birth year (Gunnersen and Bisgaard, 2010).
A range of publicly subsidized childcare programmes are
available in Denmark ranging from nurseries, municipal day
care and school care schemes to recreation centres. From
programme-specific expenditure and number of participants
in each programme available from Statistics Denmark, this
study derived age-specific per-capita childcare costs from
birth to age 18 (Statistics Denmark, 2010).
Education
Government costs for education at different ages were
included in the model based on 9 years of compulsory edu-
cation and with an optional 3 years of upper secondary edu-
cation (Danish Ministry of Education, 2009). Costs for 29% of
the population pursuing higher degrees were also included.
The per pupil government education costs are shown in
Table 1.
Pension
The costs of publicly funded pension schemes were
included, with age of retirement set at age 67, based on
new retirement laws, and inflated at 2% over time (OECD,
2009). The early retirement scheme currently available
was not included in this analysis because of uncertainty
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regarding its availability in the future. Private pensions are
not included as these are based on personal contributions
and not government expenditure.
Income
Age-specific earnings were obtained from a survey of 3.3%
of Danish households in 2007 (Danish Rational Economic
Agents Model, 2007). Wages were inflated according to
long-term productivity projections of 2% provided by the
Ministry of Finance (2007).
Tax revenue
To derive annualized government tax receipts for an aver-
age Danish citizen, this study applied age-specific propor-
tional income-tax payments and social contributions
obtained from population survey data to age-specific wages
(Danish Rational Economic Agents Model, 2007). The
age-specific proportional tax rate was held constant over
the lifetime of the model because of uncertainty regarding
future tax rates. To account for other financial transfers to
government, a 12.75% flat rate was applied to annual earn-
ings to account for value added taxes (VAT), duties and
property taxes (Gunnersen and Bisgaard, 2010).
Other government transfers
Government transfers for sickness benefits, unemployment
benefits, cash benefits, rent subsidies and rent allowances
to the elderly were included (Table 1 ).
Economic parameters
Government transfer payments and costs were assumed to
grow annually with the rate of inflation. Since 1989, the rate
of inflation in Denmark has averaged 2% and this was used as
the base inflation rate (Gunnersen and Bisgaard, 2010). The
growth in healthcare costs per capita was set at 3% to
reflect current growth rates (Gunnersen and Bisgaard,
2010).
400.000 C
Net present value naturaltv conceived child
300,000C Net present value IVF-conceived child
200,0001
-100.000 C
To reflect the present value of assisted reproduction
treatment costs and all other government transfers and
tax receipts, it was necessary to reflect future values in
present-day value using discounting. The discount rate in
the base case was 3%. However, within the current eco-
nomic environment, the discount rate published by the Dan-
ish National Bank is 0.75% that was assessed in the
sensitivity analysis (Danmarks Nationalbank, 2010).
Calculating lifetime net tax revenues
To reflect the net present value (NPV) of investment in
assisted reproductive technology, this study depreciated
treatment costs attributed to an IVF-conceived child over
the lifetime of the child (KQ). Furthermore, at each year
of life, this study derived age-specific net tax revenues from
the government perspective based on government transfers
and gross tax receipts and discounted these costs to the
base year:
t=o (1+0'
Figure 1 Discounted net tax revenue for IVF-conceived and
naturally conceived children from Danish government's
perspective.
Rt = sum gross tax revenues accruing from the individual age
t; Et = sum government expenditures on the individual age t;
r = discount rate; T=l i fe expectancy; Ko = direct IVF/ICSI
costs.
For comparison, a similar calculation was performed for
a naturally conceived child excluding assisted reproductive
technology costs. The results describe the cumulative dis-
counted net tax revenue by ages 25 and 50 as convenient
time points. The model was developed in Microsoft Excel.
Results
The trace in Figure 1 depicts the cumulative discounted net
tax revenue for an IVF/ICSI-conceived singleton and natu-
rally conceived child. During the early years of life, children
are net recipients of government transfers, noted by the
negative accumulate debt from the perspective of govern-
ment. After joining the work force and paying taxes, the
accumulated negative balance starts to improve until reach-
ing the breakeven age, i.e. the age at which all government
transfers to the child have been paid for in tax receipts. An
average individual will continue to contribute more in tax
receipts than receiving in government transfers until the
age of retirement. During retirement, individuals will nor-
mally consume more in government transfers compared
v/ith working ages, which explains the downward sloping fig-
ure during retirement.
The cumulative discount net tax revenue attributed per
IVF/ICSI-conceived and naturally conceived child by the
age 25 and 50 years is shown in Table 2. At age 25, both
IVF/ICSI-conceived and naturally conceived children are still
in negative balance with the Danish government based on
financial transfers received in relation to taxes paid, at
-€155,900 and -€145,150, respectively. By age 50, after
approximately 30 years of tax contributions, the net tax
benefit for an IVF/ICSI-conceived child whose mother was
aged <40 at the time of treatment and a naturally con-
ceived child are €154,500 and €165,200, respectively. A nat-
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Table 2 Discounted lifetime tax benefits per IVF/ICSI-conceived and naturally conceived child.
Cost per live birth (e) Year 25 (i) Year 50 (€) Breakeven age
Naturally conceived
Assisted-conceived child, mother aged <40







urally conceived child generates slightly higher net taxes for
the state because of the presumed zero cost of conception
compared with treatment costs required for IVF/ICSI-
conceived children. The breakeven ages for an IVF/ICSI-
conceived child with mother aged <40 is similar to a
naturally conceived child at age 39 and for IVF/ICSI-con-
ceived children with mother aged >40 at time of treatment.
Increases by 2 years to age 41.
To test the robustness of the base case assessment, this
study varied several parameters most Ukely to influence the
results. Applying the current discount rate of 0.75% recom-
mended by the Danish National Bank Increase, the dis-
counted future net tax revenue for IVF/ICSI-conceived and
naturally conceived children Increases to €568,400 and
€579,400, respectively. Growth in healthcare costs and
reduced productivity negatively impact the discounted net
tax revenue (Table 3).
Price sensitivity of IVF/ICSI
To project the long-term fiscal impact associated with
changes in fertility funding in Denmark, this study estimated
the fiscal Impact associated with reduced number of cycles
and live births following funding changes. Given an esti-
mated 1547 IVF/ICSI live births annually (Danish Fertility
Registry, 2010), following implementation of the new pol-
icy, the model estimated a 30-50% reduction 1n annual
IVF/ICSI births. Estimates of reduced number of births are
in Une with previous reports of price-elasticity of demand
for IVF/ICSI and healthcare 1n general (Connolly et al.,
2009a,b; Ringel et al., 2005)
The results in Table 4 describe the impact of reduced
numbers of IVF/ICSI-conceived children in a single year 1n
discounted net tax revenue for the Danish government
resulting from the policy change. By year 25, the IVF/ICSI
birth cohort still, on average, has a negative account with
the government because of accumulated transfers In early
life. However, by year 50, the IVF/ICSI birth cohort repre-
sents (-246 million 1n net tax revenue for the Danish
government. Under different scenarios of reduced births
following the policy change, the government achieves addi-
tional savings of €67 million, €90 million and €112 million by
year 25. However, by year 50 the reduced number of births
represents a loss to the government of €74 million, €99 mil-
lion and €123 million, depending on the reduced number of
IVF/ICSI-conceived births that results following introduction
of the new reimbursement system (Table 4).
Discussion
One of the most common explanations made by national
insurers for falling to fund assisted and non-assisted repro-
ductive technology is that fertility treatments are consid-
ered too expensive (McWhirter and McQueen, 2000), even
though, by comparison, treatment costs are comparable
to many other services provided by health services, and
costs make up less than 0.25% of the healthcare budget
(Connolly et al., 2010).
Ideally, subjective assessments of cost are best consid-
ered In relation to treatment benefits, which raises the
question about the most appropriate economic framework
for valuing benefits of a medical technology that creates
human life. For example, applying conventional evaluation
methods to assisted reproduction based on quality-adjusted
life years fails to capture the externality of creating human
Ufe through medical technology. Furthermore, 1n the con-
text of fertility treatments, quality-adjusted Ufe years are
only relevant 1n the context of how the treatment impacts
Infertile couples (NICE, 2004) and, when applied to fertility
treatments, do not account for the economic consequences
associated with creating a child. This 1s particularly relevant
1n Denmark where the contribution of assisted reproductive
technology to maintaining total fertility rates is well docu-
mented (Jensen et al., 2008).
One of the most Interesting features of the current anal-
ysis is how the introduction of patient co-payments will
impact government accounts differently over time. These
estimates are derived using an accepted methodological
Table 3 Sensitivity analysis of critical parameters in assisted reproduction health
investment model for assisted reproduction for mothers aged <40.
Parameters tested
Increase discount rate to 0.75%
Healthcare costs grow 4%
Healthcare costs grow 5%
Productivity growth rate 1%
Productivity growth rate 3%
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Table 4 Long-term impact on discounted net taxes attributed to funding changes to public fertility clinics from Danish




































framework used by treasury departments to derive dis-
counted net tax revenue for different age cohorts (Bonin
and Patxot, 2004). Depending on the actual numbers of
reduced births following the policy change, the government
will actually achieve additional savings from reduced num-
bers of assisted reproductive technology children born and
receiving government transfer payments (e.g. health, edu-
cation, allowances, cash transfers). An estimated additional
saving of €67-112 million can be achieved by year 25 fol-
lowing the new policy. Conversely, over a longer time hori-
zon, because of fewer assisted-conception children born,
this will translate into fewer future workers paying taxes,
even after adjusting for unemployment. By year 50, dis-
counted net tax losses to the Danish government of €74—123
million are estimated.
The analysis described here provides an alternative per-
spective to the issue of multiple pregnancies. Whilst the
medical community agrees that multiples are an undesirable
outcome, when viewed from an economic perspective the
issue 1s less clear. Within the modelling framework described
here, the 'average cost per live birth' is used as the
government-investment component and assumes a cohort
of singleton deliveries. Whilst many may argue for including
costs of multiples in this type of an analysis, a previous study
in Denmark commission by the Danish National Board of
Health concluded that, on the basis of 'costs per live birth,'
double-embryo transfer was more cost-effective compared
with single-embryo transfer (Ingerslev et al., 2005). Even
after adjusting for increased health expenditure in twin
pregnancies, when these costs are divided by two births,
the 'cost per live birth' was lower compared with sin-
gle-embryo transfer (Ingerslev et al., 2005). Had the current
analysis factored in the costs and benefits of twin pregnan-
cies, similar to those described by Ingerslev et al., twin preg-
nancies may appear to represent improved economic
outcomes compared with singletons because two future
tax payers would have been born. Therefore, to avoid inad-
vertently promoting multiple pregnancies based on future
net tax revenues from twins, this analysis was limited to only
singletons.
It is possible that the financial impact of cuts to fertility
estimates described here are an underestimate because
only IVF/ICSI live births in Danish public clinics were consid-
ered. The new policy will also impact patient treatment
costs for frozen-embryo cycles and oocyte donation, as well
as medication costs for treatment provided in public clinics.
This would suggest that the reduction in assisted reproduc-
tion live births might be much greater than those discussed
here and consequently will have a greater financial impact
over many generations. Additionally, considering similari-
ties between the proposed Danish policy and recently imple-
mented funding changes in Norway, there 1s reason to
believe that the actual number of assisted reproduction
births will be greater than estimated here, resulting in an
increased fiscal impact.
Applying a generational accounting framework to under-
stand investments in reproductive technology and other
health technologies offers advantages over traditional
approaches for evaluating programmes. Firstly, the frame-
work illustrates that concerns over cost are often
short-term concerns and that cutting costs has far-reaching
implications, both positive and negative. Furthermore,
while those working in the profession of assisted reproduc-
tion often discuss costs specifically related to treatment,
in the scheme of all other government expenses and
lifetime tax contributions these costs are almost insignifi-
cant. Additionally, it is worth considering that the frame-
work discussed here considers costs in relation to assisted
reproduction; in reality a similar analytic framework could
be applied to any medical technology that influences mor-
tality, productivity and work-force participation. However,
it is important to recognize that results obtained applying a
generational accounting framework to investments in health
do not reflect a precise forecast of the future. Rather, they
reflect a potential fiscal scenario based on prevailing
macro-economic conditions and the Interaction of these
variables over time (Prusvic and Pavlokova, 2010).
Secondly, the government perspective framework illus-
trates how government beliefs can be misaligned. In a
recent survey conducted by the United Nations with govern-
ment planners in Denmark, concerns over ageing popula-
tions were expressed (United Nations, 2003). Whilst
concerns over ageing populations are reflected in one area
of government, cuts within the health service to fertility
services that reduces birth rates that could alleviate these
concerns within other areas of government.
The debate in Denmark regarding public funding for fer-
tility treatments focuses attention on what are societal pri-
orities during an era of ageing populations, limited
healthcare resources, stagnant economic growth and the
role of the state In the provision of services. Whilst most
people desire a comprehensive and equitable health ser-
vice, societies also demand economic growth, increasing
economic prosperity and shared tax burden. At present.
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much of the debate centres on the role of government in the
economy and, of relevance to this paper, the national
health services: too much intervention may Impair growth;
too little intervention may lead to an inequitable society.
To some extent, the above concerns are reflected 1n the
debate regarding the provision of fertility services by public
providers. In many health services, infertility is a low-
priority illness that increases costs for health services that
are focused on unmet needs of present-day society. In con-
trast, many of the fiscal problems of the future are attrib-
uted to ageing populations, declining numbers of
working-age adults and increasing age-dependency ratios,
all of which are partially mitigated by assisted-conception
children, which represents 4-5% of the future workforce
in some countries (de Mouzon et al., 2010).
One of the underlying weaknesses of the current analysis
is the type of people that are likely to be influenced by the
introduction of user fees in Denmark. Previous studies have
shown that co-payments will deter couples less able to
afford treatment (Griesinger et al., 2007). Conversely, cou-
ples with increased financial resources to pay for treatment
are more likely to receive care using private funds. Based on
the observation that children born to parents with more
wealth will likely accumulate more wealth themselves
(Charles and Hurst, 2003), this could Influence the current
findings. Because the model considers average earnings 1n
the future based on universal access, this would suggest that
the smaller birth cohort of IVF children would be wealthier in
the future and more likely to pay more government taxes.
The need to ration Is unavoidable 1n all health services,
as demand for healthcare is almost limitless and resources
are finite to satisfy this demand. The question then arises
where to cut funds. Whilst cutting assisted reproduction ser-
vices can appear less controversial, the availability of public
fertility clinics and the resulting children satisfies other gov-
ernment initiatives regarding family formation and allevi-
ates concerns over ageing populations. However, making
this leap requires making hard decisions now about what is
Important in the future. For many health services, this is a
difficult leap for health services dealing with budgetary
and political demands of the present.
Acknowledgements
The authors are grateful to Karin Erb for providing data on
reproductive outcomes data from the Danish Fertility Soci-
ety Registry in Denmark. Furthermore, the authors are In-
debted to Dr Marianne Frank Hansen from the Danish
Rational Economic Agents Model for providing population
survey data used in this analysis.
The work described here was funded by Merck. No commer-
cial products are discussed in this research.
References
Bonin, H., Patxot, C , 2004. Generational Accounting as a Tool to
Assess Fiscal Sustainability: An Overview of the Methodology.
Institute for the Study of Labor, Germany, Discussion Paper No.
990.
Charles, K.K., Hurst, E., 2003. The Correlation of Wealth across
Generations. J. Polit. Econ., Vol. I l l , December2003. Available
at SSRN: http://ssrn.com/abstract=468161.
Connolly, M.P., Gallo, F., Hoorens, S., Ledger, W., 2009a. Assessing
long-run economic benefits attributed to an IVF-conceived
singleton based on projected lifetime net tax contributions in
the UK. Hum. Reprod. 24, 626-632.
Connolly, M.P., Griesinger, G., Ledger, W., Postma, M.J., 2009b.
The impact of introducing patient co-payments in Germany on
the use of IVF and ICSI: a price-elasticity of demand assessment.
Hum. Reprod. 24, 2796 2800.
Connolly, M.P., Hoorens, S., Chambers, G.M., 2010. The costs and
consequences of assisted reproductive technology: an economic
perspective. Hum. Reprod. Update 16, 603-613.
Danish Fertility Registry data, August 2010. Fertility data provided
by data administrator.
Danish Ministry of Education (DME). Key figures in Education 2009.
Statistical Publication no. 2 (2010).
Danish Rational Economic Agents Model (DRE/WA). Population level
survey collected in 2007. Available from: <http://wv/w.dream-
model.dk/>. (accessed 30.05.11).
Danmarks Nationalbank. Interest Rate Increase. Press Release 14
October 2010. Available from: <http://www.nationalban-
ken.dk/>. (accessed 31.05.11).
de Mouzon, J., Goossens, V., Bhattacharya, S., Castilla, J.A.,
Ferraretti, A.P., Korsak, V., et al., 2010. Assisted reproductive
technology in Europe, 2006: results generated from European
registers by ESHRE. Hum. Reprod. 25, 1851-1862.
Elshaug, A.G., Moss, J.R., Littlejohns, P., Karnon, B.J., Merlin,
T.L., Karnon, J., Hiller, J.E., 2009. Identifying existing health
care services that do not provide value for money. Med. J. Aust.
190, 269-273.
Griesinger, G., Diedrich, K., Altgassen, C , 2007. Stronger reduction
of assisted reproduction technique treatment cycle numbers in
economically weak geographical regions following the German
healthcare modernization law in 2004. Hum. Reprod. 22,
3027-3030.
Gunnersen, S.J., Bisgaard, M.P. (Eds.). Statistics Denmark, Statis-
tical Yearbook 2010. Published by Statistics Denmark; June 2010
114th ed.
Hoorens, S., Conklin, A., Tiessen, J., 2008. Between politics and
clinics-the many faces of biomédical policy in Europe: Analysis
of drivers and outcomes of Assisted Reproductive Technologies
policy, RAND. Cambridge, RAND Corporation.
Ingerslev, H.J., Poulsen, P.B., Kesmodel, U., Hojgaard, A., Pinborg,
A., Henriksen, T.B., Seeberg, J., Ottosen, L.D., 2005. Should
one or two embryos be transferred in IVP? A health technology
assessment. Danish Health Technology Assessment 7, Copenha-
gen: National Board of Health, Danish Centre for Evaluation and
Health Technology Assessment.
Jensen, T.K., Sobotka, T., Hansen, M.A., Pedersen, A.T., Lutz, W.,
Skakkebaek, N.E., 2008. Lining trends in conception rates in
recent birth cohorts of native Danish women: a possible role of
deteriorating male reproductive health. Int. J. Androl. 31,
81-92.
Jones, H.W., Cohen, J., Cooke, I., Kempers, R., 2007. IFFS
Surveillance 07. Fértil. Steril. 87, S14-S16.
Kotlikoff, L., 1992. Generational Accounting: Knowing Who Pays,
and When, for What We Spend. Free Press, New York.
Leunens, L., Celestin-Westreich, S., Bonduelle, M., Liebaers, I.,
Ponjaert-Kristoffersen, I., 2008. Follow-up of cognitive and
motor development of 10-year-old singleton children born after
ICSI compared with spontaneously conceived children. Hum.
Reprod. 23, 105-111.
Lovforslag nr. L. 45. Forslag til 'Lov om aendring af
kunstig befrugtning i forbindetse med laegelig behandling,
diagnostik og forskning m.v. samt sundhedsloven. Folketingsti-
dende A (2010). (Bill No. L. 45th Draft 'Law on amendment of
artificial insemination in connection with medical treat-
ment, diagnostics and research, etc. and Health Act. Folket-
ingstidende A).
Fertility funding and net taxes in Denmark 837
McWhirter, M., McQueen, D., 2000. Rationing and NHS fertility
services: a commissioning perspective. Hum. Fértil. 3,
271-274.
Ministry of Finance (MoF). Colophon - Denmark's Convergence
Programme 2007. ISBN, electronic version: 87-7856-860-9.




National Institute for Clinical Excellence (NICE), 2004. Fertility
assessment and treatment for people v^ith fertility problems.
Published by the RCOG Press at the Royal College of Obstetri-
cians and Gynaecologists, 27 Sussex Place, London.
OECD, 2009. Pensions at a glance 2009: retirement-income systems
in OECD countries, ISBN: 9789264060715.
Onaran, 0., 2010. Fiscal Crisis in Europe or a Crisis of Distribution?
Political Economy Research Institute, Working Paper 226.
Prusvic, D., Pavlokova, K., 2010. Generational accounting in
European health care systems. Czech J. Econ. Finance 60,
378-399.
Royal Danish Ministry of Foreign Affairs (RDMFA). Fifth periodic
report of Denmark concerning the international covenant on
economic, social, and cultural rights. December 2009.
Ringel, J.S., Hosek, S.D., VoUaard, B.A., Mahnoversuski, S., 2005.
The elasticity of demand for health care: a review of the
literature and its application to the military health system.
RAND Monograph, ISBN/EAN: 0-8330-3109-0.
Schulz, E., 2010. The long-term care system in Denmark. ENEPRI
Research Report No. 73; ISBN 978-94-6138-015-9.
Statistics Denmark. StatBank Denmark. Available from:
< http: / /wv/w.statistikbanken.dk/statbank5a/default.asp?w= 1280>.
(accessed 31.05.11).
Stuckler, D., Basu, S., McKee, M., 2010. Budget crises, health, and
social welfare programmes. BMJ 341, 77-79.
Svensson, A., Connolly, M., Gallo, F., Häggtund, L., 2008. Long term
fiscal implications of subsidizing in-vitro fertilization in Sweden:
a lifetime tax perspective. Scand. J. Public Health 36, 832-840.
Thaele, M., Uszkoreit, M., 2007. Legislature's impact on the
outcome of infertility treatments - the German political
contradiction. Pharm Policy Law 9, 221-227.
United Nations, 2003. Department of Economic and Social Affairs
Population Division. World Population Policies 2007. Copyright ©
United Nations, 2008. ST/ESA/SER.A/272.
Ar\ abbreviated set of results discussed in this paper were
presented at a special hearing to the Danish Parliament on 25
October 2010.
Declaration: The funding organization had no influence on con-
ducting the analysis and reporting of the results, other than
academic contributions provided by SC.
MPC received research support from and has served as a consultant
for Merck. MJP received research support from Merck. SC is an
employee of Merck. ANA and SZ report no financial or commercial
conflicts of interest.
Received 1 June 2011; refereed 15 August 2011; accepted 19
September 2011.
Copyright of Reproductive BioMedicine Online (Reproductive Healthcare Limited) is the property of
Reproductive Healthcare Limited and its content may not be copied or emailed to multiple sites or posted to a
listserv without the copyright holder's express written permission. However, users may print, download, or
email articles for individual use.
